You are on the new improved site. You can view the old site in view-only mode here until June 27, 2026

Filter Results

Search all journals

Enter search terms…

Advanced search

/

About

About Sage
About Sage Journals
Privacy Policy
Terms of Use
Contact Us
Help

Information for

Authors
Editors
Librarians
Researchers
Reviewers
Frequently asked questions

Copyright © 2026 by Sage Publications.京ICP备09090397号-11

Search results

Search results page

Articles (23)

Journals (0)

1-10 of 23 results for Ado-trastuzumab emtansine

Sort by:

Relevance

Select all

Select all

Sort by:

Relevance

Select article: The role of ado-trastuzumab emtansine in current clinical practice

Retricted access

Review article

First published 2021-1

The role of ado-trastuzumab emtansine in current clinical practice

Alla Turshudzhyan

Journal of Oncology Pharmacy Practice

Select article: Ado-trastuzumab Emtansine

Retricted access

Review article

First published 2014-11

Ado-trastuzumab Emtansine

Patricia A. Corrigan, Teresa A. Cicci, Jessica Johnston Auten [...]

Annals of Pharmacotherapy

Select article: Ado-trastuzumab emtansine associated spider telangiectasia

Retricted access

Case report

First published 2022-6

Ado-trastuzumab emtansine associated spider telangiectasia

Pınar Gursoy, Ayda Acar, Taner Acikalin

Journal of Oncology Pharmacy Practice

Select article: Ado-trastuzumab emtansine: Avoiding side-effects of traditional HER2 positive breast cancer treatment

Retricted access

Case report

First published 2021-10

Ado-trastuzumab emtansine: Avoiding side-effects of traditional HER2 positive breast cancer treatment

Alla Turshudzhyan, James Vredenburgh

Journal of Oncology Pharmacy Practice

Select article: Ado-trastuzumab emtansine (T-DM1): a novel antibody-drug conjugate for the treatment of HER2-positive metastatic breast cancer

Retricted access

Review article

First published 2015-4

Ado-trastuzumab emtansine (T-DM1): a novel antibody-drug conjugate for the treatment of HER2-positive metastatic breast cancer

Jessica M Baron, Bonnie L Boster, Chad M Barnett

Journal of Oncology Pharmacy Practice

Select article: Ado-trastuzumab emtansine (T-DM1) in human epidermal growth factor receptor 2 (HER2)-positive metastatic breast cancer: latest evidence and clinical potential

Free access

Review article

First published 2014-9

Ado-trastuzumab emtansine (T-DM1) in human epidermal growth factor receptor 2 (HER2)-positive metastatic breast cancer: latest evidence and clinical potential

Parvin F. Peddi, Sara A. Hurvitz

Therapeutic Advances in Medical Oncology

Select article: Prognostic factors of ado-trastuzumab emtansine treatment in patients with metastatic HER-2 positive breast cancer

Retricted access

Research article

First published 2021-4

Prognostic factors of ado-trastuzumab emtansine treatment in patients with metastatic HER-2 positive breast cancer

Deniz Tataroglu Ozyukseler, Mustafa Basak, Seval Ay [...]

Journal of Oncology Pharmacy Practice

Select article: Telangiectasias induced by combination tucatinib and ado-trastuzumab emtansine in a patient with metastatic breast cancer

Open access

Case report

First published 2024-04-01

Telangiectasias induced by combination tucatinib and ado-trastuzumab emtansine in a patient with metastatic breast cancer

Gabriella F. Rodriguez, Anuj Shah, Andrea D. Maderal

Breast Disease

Select article: Impact of obesity on safety outcomes and treatment modifications with ado-trastuzumab emtansine in breast cancer patients

Retricted access

Research article

First published 2022-1

Impact of obesity on safety outcomes and treatment modifications with ado-trastuzumab emtansine in breast cancer patients

Anna Lee, Chris Larck, Donald C Moore

Journal of Oncology Pharmacy Practice

Select article: Ado-Trastuzumab Emtansine and Radium 223 Dichloride

Retricted access

Research article

First published 2013-9

Ado-Trastuzumab Emtansine and Radium 223 Dichloride

Dominic A. Solimando, J. Aubrey Waddell

Hospital Pharmacy

1
2
3
10 / page

Article type

Publication date

Subjects

Access